Stocks making the biggest moves premarket: Palantir Technologies, PayPal, Intel,
Check out the companies making headlines before the bell: PayPal — Shares gained nearly 3% after PayPal reported first quarter
Read More
Pfizer Inc
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a
Read More
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human
Read More
AI disruption didn’t show up in Salesforce results. But the fears are hard to shake
Salesforce on Wednesday evening delivered better-than-expected 2026 fourth-quarter results as its Agentforce artificial intelligence platform became increasingly embedded across the
Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a
Read More
Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more
Check out the companies making headlines before the bell: Novo Nordisk — The maker of obesity drug Wegovy’s U.S. stock
Read More
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday said its experimental obesity drug, which it acquired through
Read More
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its
Read More